JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1985; 6:737-743
© 1985 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cueto-Garcia, L
Right arrow Articles by Tajik, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cueto-Garcia, L
Right arrow Articles by Tajik, A.

Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival

L Cueto-Garcia, GS Reeder, RA Kyle, DL Wood, JB Seward, J Naessens, KP Offord, PR Greipp, WD Edwards, and AJ Tajik

One hundred thirty-two patients with biopsy-proven systemic amyloidosis underwent echocardiographic examination to define the spectrum of cardiac involvement. Echocardiographic abnormalities were then correlated with clinical variables and survival at follow-up. Patients were subgrouped by left ventricular wall thickness: Group I, mean wall thickness 12 mm or less; Group II, mean wall thickness greater than 12 mm but less than 15 mm; Group III, mean wall thickness 15 mm or greater; or Group IV, atypical features such as wall motion abnormalities or left ventricular dilation. Patients with greater wall thickness had a higher frequency of associated echocardiographic abnormalities such as left atrial enlargement or granular sparkling appearance on two-dimensional examination and, more commonly, reduced systolic function. The occurrence of clinical congestive heart failure was strongly correlated with greater wall thickness and multiple other echocardiographic abnormalities. Survival was negatively influenced both by greater wall thickness and reduced systolic function. The median survival of the entire group was 1.1 years. Echocardiographic examination is an important tool for establishing the presence of cardiac amyloid involvement and may be useful in estimating prognosis in such patients.


This article has been cited by other articles:


Home page
Eur J EchocardiogrHome page
A. D'Aloia, E. Vizzardi, E. Chiari, P. Faggiano, A. Squeri, F. Ugo, and L. D. Cas
Cardiac arrest in a patient with a mobile right atrial thrombus in transit and amyloidosis
Eur J Echocardiogr, January 1, 2008; 9(1): 141 - 142.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
K. M. Modesto, A. Dispenzieri, M. Gertz, S. A. Cauduro, B. K. Khandheria, J. B. Seward, R. Kyle, C. M. Wood, K. R. Bailey, A. J. Tajik, et al.
Vascular abnormalities in primary amyloidosis
Eur. Heart J., April 12, 2007; (2007) ehm066v1.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
K. B. Shah, Y. Inoue, and M. R. Mehra
Amyloidosis and the heart: a comprehensive review.
Arch Intern Med, September 25, 2006; 166(17): 1805 - 1813.
[Abstract] [Full Text] [PDF]


Home page
Eur J EchocardiogrHome page
P. Lindqvist, B.O. Olofsson, C. Backman, O. Suhr, and A. Waldenstrom
Pulsed tissue Doppler and strain imaging discloses early signs of infiltrative cardiac disease: A study on patients with familial amyloidotic polyneuropathy
Eur J Echocardiogr, January 1, 2006; 7(1): 22 - 30.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
K. M. Modesto, A. Dispenzieri, S. A. Cauduro, M. Lacy, B. K. Khandheria, P. A. Pellikka, M. Belohlavek, J. B. Seward, R. Kyle, A. J. Tajik, et al.
Left atrial myopathy in cardiac amyloidosis: implications of novel echocardiographic techniques
Eur. Heart J., January 2, 2005; 26(2): 173 - 179.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. Dispenzieri, M. A. Gertz, R. A. Kyle, M. Q. Lacy, M. F. Burritt, T. M. Therneau, P. R. Greipp, T. E. Witzig, J. A. Lust, S. V. Rajkumar, et al.
Serum Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide: A Staging System for Primary Systemic Amyloidosis
J. Clin. Oncol., September 15, 2004; 22(18): 3751 - 3757.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Dispenzieri, M. A. Gertz, R. A. Kyle, M. Q. Lacy, M. F. Burritt, T. M. Therneau, J. P. McConnell, M. R. Litzow, D. A. Gastineau, A. Tefferi, et al.
Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation
Blood, September 15, 2004; 104(6): 1881 - 1887.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. E. Rahman, E. F. Helou, R. Gelzer-Bell, R. E. Thompson, C. Kuo, E. R. Rodriguez, J. M. Hare, K. L. Baughman, and E. K. Kasper
Noninvasive diagnosis of biopsy-proven cardiac amyloidosis
J. Am. Coll. Cardiol., February 4, 2004; 43(3): 410 - 415.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Koyama, P. A. Ray-Sequin, and R. H. Falk
Longitudinal Myocardial Function Assessed by Tissue Velocity, Strain, and Strain Rate Tissue Doppler Echocardiography in Patients With AL (Primary) Cardiac Amyloidosis
Circulation, May 20, 2003; 107(19): 2446 - 2452.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Koyama, P. A. Ray-Sequin, and R. H. Falk
Prognostic Significance of Ultrasound Myocardial Tissue Characterization in Patients With Cardiac Amyloidosis
Circulation, July 30, 2002; 106(5): 556 - 561.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A.K.L. Reyners, B.P.C. Hazenberg, W.D. Reitsma, and A.J. Smit
Heart rate variability as a predictor of mortality in patients with AA and AL amyloidosis
Eur. Heart J., January 2, 2002; 23(2): 157 - 161.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. Dingli, J. P. Utz, and M. A. Gertz
Pulmonary Hypertension in Patients With Amyloidosis
Chest, November 1, 2001; 120(5): 1735 - 1739.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Liao, M. Jain, P. Teller, L. H. Connors, S. Ngoy, M. Skinner, R. H. Falk, and C. S. Apstein
Infusion of Light Chains From Patients With Cardiac Amyloidosis Causes Diastolic Dysfunction in Isolated Mouse Hearts
Circulation, October 2, 2001; 104(14): 1594 - 1597.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
T. G. DiSalvo, M. E. King, and R. N. Smith
Case 3-2000- A 66-Year-Old Woman with Diabetes, Coronary Disease, Orthostatic Hypotension, and the Nephrotic Syndrome
N. Engl. J. Med., January 27, 2000; 342(4): 264 - 273.
[Full Text] [PDF]


Home page
ThoraxHome page
J. D Gillmore and P. N Hawkins
Amyloidosis and the respiratory tract
Thorax, May 1, 1999; 54(5): 444 - 451.
[Full Text]


Home page
NEJMHome page
R. H. Falk, R. L. Comenzo, and M. Skinner
The Systemic Amyloidoses
N. Engl. J. Med., September 25, 1997; 337(13): 898 - 909.
[Full Text] [PDF]


Home page
NEJMHome page
J. Reisinger, S. W. Dubrey, R. H. Falk, D. H. Spodick, S. S. Kushwaha, J. T. Fallon, and V. Fuster
Restrictive Cardiomyopathy
N. Engl. J. Med., June 26, 1997; 336(26): 1917 - 1918.
[Full Text]


Home page
NEJMHome page
S. S. Kushwaha, J. T. Fallon, and V. Fuster
Restrictive Cardiomyopathy
N. Engl. J. Med., January 23, 1997; 336(4): 267 - 276.
[Full Text] [PDF]


Home page
BMJHome page
R Hall and P N Hawkins
Grand Rounds - Hammersmith Hospital: Cardiac transplantation for AL amyloidosis
BMJ, October 29, 1994; 309(6962): 1135 - 1137.
[Full Text]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1985 by the American College of Cardiology Foundation.